Petra Schuberth

837 total citations
11 papers, 446 citations indexed

About

Petra Schuberth is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Petra Schuberth has authored 11 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Petra Schuberth's work include CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (2 papers). Petra Schuberth is often cited by papers focused on CAR-T cell therapy research (8 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (2 papers). Petra Schuberth collaborates with scholars based in Switzerland, United States and Germany. Petra Schuberth's co-authors include Ulf Petrausch, Christoph Renner, Rolf A. Stahel, Alex Soltermann, Axel Mischo, Shawn M. Jensen, Sarah C. Saunderson, Barry D. Hock, Alexander D. McLellan and Norbert Koch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Petra Schuberth

9 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petra Schuberth Switzerland	7	289	185	140	81	78	11	446
Ekaterina Zmievskaya Russia	10	291 1.0×	166 0.9×	177 1.3×	75 0.9×	38 0.5×	18	452
Cody E. Cotner United States	4	464 1.6×	136 0.7×	183 1.3×	89 1.1×	66 0.8×	10	537
Pilvi Maliniemi Finland	10	272 0.9×	248 1.3×	138 1.0×	92 1.1×	58 0.7×	16	505
Amirhossein Mardi Iran	11	190 0.7×	164 0.9×	129 0.9×	62 0.8×	96 1.2×	30	411
Axel Hyrenius‐Wittsten Sweden	7	277 1.0×	249 1.3×	117 0.8×	70 0.9×	74 0.9×	11	621
Guoxiu Du China	6	397 1.4×	131 0.7×	233 1.7×	72 0.9×	23 0.3×	6	516
Daniel Michaud United States	7	384 1.3×	117 0.6×	313 2.2×	57 0.7×	47 0.6×	11	527
Anna C. Filley United States	7	315 1.1×	133 0.7×	225 1.6×	127 1.6×	41 0.5×	10	547
Tamara Laskowski United States	7	395 1.4×	201 1.1×	403 2.9×	76 0.9×	43 0.6×	8	645
Shutan Jiang China	6	292 1.0×	208 1.1×	225 1.6×	41 0.5×	68 0.9×	7	507

Countries citing papers authored by Petra Schuberth

Since Specialization

Citations

This map shows the geographic impact of Petra Schuberth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Schuberth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Schuberth more than expected).

Fields of papers citing papers by Petra Schuberth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Schuberth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Schuberth. The network helps show where Petra Schuberth may publish in the future.

Co-authorship network of co-authors of Petra Schuberth

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Schuberth. A scholar is included among the top collaborators of Petra Schuberth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Schuberth. Petra Schuberth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Abonour, Rafat, Amani Kitali, A Trovato, et al.. (2024). P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs). Clinical Lymphoma Myeloma & Leukemia. 24. S40–S41.

Sidana, Surbhi, Christof Scheid, Petra Schuberth, et al.. (2024). Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3476–3476.

Eichhorst, Barbara, Kieron Dunleavy, Enrico Tiacci, et al.. (2023). Zuma-25: A Phase 2 Study of Brexucabtagene Autoleucel (KTE-X19) Chimeric Antigen Receptor T-Cell Therapy in Adult Patients with Relapsed/Refractory Rare B-Cell Malignancies. Transplantation and Cellular Therapy. 29(2). S390–S391. 1 indexed citations

Wayne, Alan S., Van Huynh, Nobuko Hijiya, et al.. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 108(3). 747–760. 26 indexed citations

Shah, Bijal, Armin Ghobadi, Olalekan O. Oluwole, et al.. (2022). Two-year follow-up of KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in adult patients (Pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3.. Journal of Clinical Oncology. 40(16_suppl). 7010–7010. 7 indexed citations

Schuberth, Petra, et al.. (2015). FAP-specific re-directed T cells first in-man study in malignant pleural mesothelioma: experience of the first patient treated. Journal for ImmunoTherapy of Cancer. 3(S2). 9 indexed citations

Schuberth, Petra, Shawn M. Jensen, Maries van den Broek, et al.. (2013). Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. Journal of Translational Medicine. 11(1). 187–187. 159 indexed citations

Schuberth, Petra, Markus Thiel, Gerhard Held, et al.. (2013). Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system.. PubMed. 33(10). 4189–201. 6 indexed citations

Petrausch, Ulf, Petra Schuberth, Alex Soltermann, et al.. (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer. 12(1). 615–615. 64 indexed citations

10.

Schuberth, Petra, Shawn M. Jensen, Andreas Wadle, et al.. (2012). Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma. Gene Therapy. 20(4). 386–395. 49 indexed citations

11.

Saunderson, Sarah C., Petra Schuberth, Amy C. Dunn, et al.. (2008). Induction of Exosome Release in Primary B Cells Stimulated via CD40 and the IL-4 Receptor. The Journal of Immunology. 180(12). 8146–8152. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact